ACHV Logo

Achieve Life Sciences, Inc. (ACHV) Insider Trading Activity

NASDAQ$2.65
Market Cap
$91.92M
Sector
Healthcare
Industry
Biotechnology
Rank in Sector
318 of 878
Rank in Industry
181 of 506

Largest Insider Buys in Sector

$337M
$259M
$79M
$76M
$60M
$57M

ACHV Insider Trading Activity

ACHV Median Price and Trade Amounts History Chart

Statistics of Insider Transactions

Amount of Insider Buys and Sells

Buys
$57,485
2
100
Sells
$0
0
0

Related Transactions

Oki Mark KChief Financial Officer
1
$28,887
0
$0
$28,887
Stewart Richard AlistairChieve Executive Officer
1
$28,598
0
$0
$28,598

About Achieve Life Sciences, Inc.

Achieve Life Sciences, Inc., a clinical-stage pharmaceutical company, develops and commercializes of cytisinicline for smoking cessation and nicotine addiction in Canada, the United States, and the United Kingdom. The company offers cytisinicline, a plant-based alkaloid that interacts with nicotine receptors in the brain that reduce the severity of nicotine withdrawal symptoms. It has license agreements with Sopharma AD and University of Bristol. The company is based in Vancouver, Canada.

Insider Activity of Achieve Life Sciences, Inc.

Over the last 12 months, insiders at Achieve Life Sciences, Inc. have bought $57,485 and sold $0 worth of Achieve Life Sciences, Inc. stock.

On average, over the past 5 years, insiders at Achieve Life Sciences, Inc. have bought $54,671 and sold $0 worth of stock each year.

Highest buying activity among insiders over the last 12 months: Oki Mark K (Chief Financial Officer) — $28,887. Stewart Richard Alistair (Chieve Executive Officer) — $28,598.

The last purchase of 10,000 shares for transaction amount of $28,598 was made by Stewart Richard Alistair (Chieve Executive Officer) on 2025‑03‑17.

List of Insider Buy and Sell Transactions, Achieve Life Sciences, Inc.

2025-03-17PurchaseStewart Richard AlistairChieve Executive Officer
10,000
0.0283%
$2.86
$28,598
-15.03%
2025-03-17PurchaseOki Mark KChief Financial Officer
10,000
0.0286%
$2.89
$28,887
-15.03%
2024-03-04PurchaseBencich JohnCEO
10,000
0.0492%
$4.58
$45,850
+2.26%
2024-03-04PurchaseStewart Richard AlistairExecutive Chairman
10,000
0.0492%
$4.58
$45,850
+2.26%
2023-05-30PurchaseBencich JohnCEO
5,000
0.0246%
$5.50
$27,500
-26.36%
2022-11-18PurchaseBencich JohnCEO
22,000
–
$0
$0
+108.16%
2021-05-27PurchaseBencich JohnCEO
6,000
0.0716%
$7.00
$42,000
-3.40%
2019-06-11SaleARMISTICE CAPITAL, LLC10 percent owner
312,145
4.6633%
$3.11
$972,288
-71.03%
2019-06-11PurchaseARMISTICE CAPITAL, LLC10 percent owner
12,813
0.2335%
$3.80
$48,689
-71.03%
2019-05-23PurchaseStewart Richard AlistairChairman & CEO
17,500
0.2417%
$3.61
$63,093
-74.93%
2016-08-19SaleBencich JohnCFO
2,760
0.0092%
$0.57
$1,573
-21.05%
2016-06-13SaleCormack Scott DanielPresident and CEO
9,712
0.032%
$1.03
$9,959
-50.96%
2016-06-13SaleJACOBS CINDYEVP, CMO
2,874
0.0095%
$1.03
$2,947
-50.96%
2016-03-15SaleCormack Scott DanielPresident and CEO
24,066
0.0807%
$0.83
$19,975
-30.12%
2016-03-15SaleJACOBS CINDYEVP, CMO
6,508
0.0218%
$0.83
$5,402
-30.12%
2016-03-15SaleBencich JohnCFO
1,668
0.0056%
$0.83
$1,384
-30.12%
2015-08-18SaleBencich JohnCFO
2,854
0.0103%
$2.76
$7,877
-62.45%
2015-06-12SaleCormack Scott DanielPresident and CEO
9,142
0.0381%
$2.69
$24,592
-56.36%
2015-06-12SaleJACOBS CINDYEVP, CMO
2,816
0.0117%
$2.69
$7,575
-56.36%
2015-05-20SaleCormack Scott DanielPresident and CEO
15,086
0.0639%
$1.88
$28,362
+11.11%
Total: 69
*Gray background shows transactions not older than one year

Insider Historical Profitability

<0.0001%
Stewart Richard AlistairChieve Executive Officer
60876
0.1755%
$161,321.4030
<0.0001%
Oki Mark KChief Financial Officer
10000
0.0288%
$26,500.0010
COHEN STEVEN A/SAC CAPITAL MGMT LP10 percent owner
1454752
4.1942%
$3.86M10
S A C CAPITAL MANAGEMENT L L C10 percent owner
1454752
4.1942%
$3.86M10
SAC CAPITAL ADVISORS LLC10 percent owner
1454752
4.1942%
$3.86M10
ARMISTICE CAPITAL, LLC10 percent owner
1026000
2.958%
$2.72M11
<0.0001%
SAC CAPITAL ASSOCIATES LLC10 percent owner
902376
2.6016%
$2.39M10
H.I.G. ONCOGENEX, INC.10 percent owner
545512
1.5728%
$1.45M02
Cormack Scott DanielPresident and CEO
129428
0.3732%
$342,984.20112
JACOBS CINDYEVP, CMO
77416
0.2232%
$205,152.4008
Bencich JohnCEO
76724
0.2212%
$203,318.6043
<0.0001%
VENTURES WEST CAPITAL LTD10 percent owner
41763
0.1204%
$110,671.9501
Anderson Stephen CharlesCFO and Secretary
13000
0.0375%
$34,450.0030
MARTINO MICHAEL A
11000
0.0317%
$29,150.00010
DUNBAR GEORGE W JRdirector
3250
0.0094%
$8,612.5010
Lawrence Cameron WilliamPrincipal Financial Officer
3050
0.0088%
$8,082.5010
PARKER H STEWARTdirector
3000
0.0086%
$7,950.0010
IVY ROBERT Edirector
1700
0.0049%
$4,505.0005
Wyrick Susan D.PAO
1312
0.0038%
$3,476.8003
GOLDSTEIN JACKdirector
1000
0.0029%
$2,650.0010
MATTINGLY MARTIN Adirector
1000
0.0029%
$2,650.0010
WINSTEAD DWIGHTdirector
0
0%
$002
*Gray background shows insiders who have made transactions during last year

Historical Insider Profitability vs. Competitors

$30,470,407
140
20.39%
$89.85M
$4,968,419
139
5.13%
$85.97M
$49,091,668
110
13.11%
$88.84M
$16,245,616
40
123.58%
$94.82M
$909,129
37
42.19%
$86.35M
$140,938,207
36
14.75%
$91.84M
$7,147,964
34
24.78%
$91.51M
$36,079,815
31
43.23%
$94.84M
$40,617,659
23
2.15%
$97.16M
$1,239,833
16
53.23%
$94.25M
$277,862
15
59.79%
$90.84M
$135,589,307
10
32.46%
$86.89M
Achieve Life Sciences, Inc.
(ACHV)
$272,982
6
-28.53%
$91.92M
$401,951
4
57.41%
$90.85M
$16,003,671
3
55.38%
$95.63M
$30,149,552
3
-66.74%
$96.27M
$9,999,990
2
25.53%
$93.95M
$1,250
1
278.21%
$93.58M
$3,620
1
94.16%
$96.34M

ACHV Institutional Investors: Active Positions

Increased Positions36+60%595,713+3.43%
Decreased Positions18-30%1M-8.54%
New Positions10New307,785New
Sold Out Positions4Sold Out141,796Sold Out
Total Postitions78+30%16M-5.11%

ACHV Ownership Change vs Market

Institutional Investor Ownership

Top Shareholders
Top Buyers
Top Sellers
New Shareholders
Sold-Out Shareholders
Active Shareholders
Franklin Resources Inc$9,900.0011.01%3.85M-19,113-0.49%2024-12-31
Propel Bio Management, Llc$6,304.007.01%2.45M00%2024-12-31
Blackrock, Inc.$5,279.005.87%2.05M-32,486-1.56%2025-03-31
Vanguard Group Inc$4,497.005%1.75M-190,597-9.82%2024-12-31
Sofinnova Investments, Inc.$3,358.003.73%1.31M-207,550-13.71%2024-12-31
Geode Capital Management, Llc$1,943.002.16%755,845+6,736+0.9%2024-12-31
Nantahala Capital Management, Llc$1,681.001.87%654,00000%2024-12-31
State Street Corp$1,122.001.25%436,470+4,950+1.15%2024-12-31
Alyeska Investment Group, L.P.$1,082.001.2%421,000-50,000-10.62%2024-12-31
Northern Trust Corp$1,071.001.19%416,796+43,682+11.71%2024-12-31

Financial Ratios

Summary
Comparison with Competitors

Price to Earnings

Price/Earnings to Growth

Price to Sales

Price to Book

Price/Free Cash Flow

Analyst Recommendations

Analyst Price Targets

Company
About Prismo.proIdeasArticlesPrivacy PolicyTerms of ServiceContact Us
Screener Ideas
Dividend StocksBlue Chip StocksDefensive StocksGrowth StocksValue StocksCyclical StocksPenny Stocks
Stock Tools
Insiders ScreenerStocks ScreenerTop StocksStock NewsInsider RatioList of All Stocks
Prismo does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. Prismo does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.